Insulin Types for Diabetes: Complete Guide to Onset, Peak, Duration, and Use

Insulin therapy is tailored using formulations with distinct pharmacokinetic profiles. All times are approximate; individual variation exists.

TypeExamplesOnsetPeakDurationPrimary Use
Rapid-actingLispro, Aspart, Glulisine15 min1–2 h3–5 hMealtime, correction
Short-acting (Regular)Humulin R, Novolin R30–60 min2–4 h5–8 hMealtime (less used now)
Intermediate (NPH)Humulin N, Novolin N1–2 h4–12 h12–18 hBasal, BID
Long-acting (Basal)Glargine U100/U300, Detemir, Degludec1–2 hFlat/none24–42 hOnce-daily basal
Premixed70/30, 50/50, 75/25VariesDualVariesFixed ratio, BID
ConcentratedU200, U300, U500VariesVariesExtendedHigh insulin resistance

Key Clinical Pearls

  • Rapid-acting analogs preferred over regular for mealtime (faster on/off).
  • Long-acting basal analogs (glargine, degludec) have lower hypoglycemia risk than NPH.
  • Degludec U200/U300: ultra-long, flexible dosing window.
  • Inhaled insulin (Afrezza): ultra-rapid, mealtime only.
  • Pump therapy: Uses rapid-acting only for both basal (continuous) and bolus.

Regimen selection requires endocrinologist/diabetes educator collaboration.

Diabetes - Related Articles